Eli Lilly | Należności Handlowe



Trade Debtors Zmiana Data
AbbVie USD 10.92B 553M 2024-12
Abbott USD 7.05B 197M 2024-09
ALKERMES USD 394.72M 24.54M 2024-12
Amgen USD 6.78B 535M 2024-12
AstraZeneca USD 14.83B 1.28B 2024-12
Baxter International USD 1.73B 53M 2024-12
Biogen USD 1.87B 119.3M 2024-12
Bristol-Myers Squibb USD 14.42B 471M 2024-12
Drreddys Laboratories INR 111.49B 8.65B 2024-12
Eli Lilly USD 13.28B 1.22B 2024-12
Gilead Sciences USD 4.42B 167M 2024-12
GlaxoSmithKline GBP 7.32B 542M 2024-12
Glaxosmithkline GBP 7.32B 542M 2024-12
Indivior 271M 10M 2024-09
J&J USD 14.84B 1.33B 2024-12
Medtronic USD 6.12B 145M 2025-01
Merck USD 11.12B 1.06B 2024-12
Neurocrine Biosciences USD 479.1M 2M 2024-12
Novartis USD 9B 854M 2024-12
Novartis USD 7.56B 594M 2024-12
Novo Nordisk 79.63B 3.5B 2024-09
Perrigo USD 686.2M 99.7M 2024-12
Pfizer USD 14.78B 2.92B 2024-12
Prestige Brands USD 167.27M 3.73M 2024-12
Regeneron Pharmaceuticals USD 6.21B 6B 2024-12
Roche Holding CHF 13.46B 984M 2024-12
Sanofi 8.8B 2.24B 2024-06
Sanofi 8.8B 2.24B 2024-06
United Therapeutics USD 279.3M 62.5M 2024-12
Zoetis USD 1.32B 95M 2024-12



Eli Lilly Należności Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.